Background Since the release of the first global hepatitis elimination targets in 2016, and
until the COVID-19 pandemic started in early 2020, many countries and territories were …

Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Most direct‐acting antivirals (DAAs) that are being developed as therapy against hepatitis C
virus target the NS3/4A protease, the NS5A protein, and the NS5B polymerase. The latter …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Since December 2019, patients with unexplained pneumonia have been found in Wuhan,
Hubei Province, China, which was caused by a novel coronavirus that had not been …

Background & Aims Coronavirus disease 2019 (COVID-19) poses a major health threat to
healthy individuals and those with comorbidities, but its impact on patients with cirrhosis is …

Although annular fibrosis is the hallmark of cirrhosis, other microscopic changes that affect
liver function such as sinusoid capillarization or loss of metabolic zonation are common. A …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

Correspondence 390 www. thelancet. com/gastrohep Vol 7 May 2022 at least two different
mechanisms of action. Views were divided on the failure of immunomodulators, with 252 …

Background & Aims Coronavirus disease 2019 (COVID-19) has placed a significant strain
on national healthcare systems at a critical moment in the context of hepatitis elimination …